Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000465

Options or other derivatives

  • Chief Executive Officer acquired 33,920 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BLATT LAWRENCE · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +33,920 33,920 D
Loading xslF345X05/form4.xml…